THE SHIFT
Procedures are moving to ASCs and outside the OR. The rescue equipment isn't.
Payers and CMS are moving surgery and sedation out of the hospital ORs.
The patients are older, heavier, and more likely to have sleep apnea.
They're going to sites with no ICU down the hall and no respiratory therapist on call.
+50%
Non-operating room anesthesia (NORA) cases are projected to exceed half of total anesthesia cases in the near future.
87%
of US surgeries are ambulatory
30 Million
Americans affected by obstructive sleep apnea, with an estimated 80% of cases undiagnosed at the time of procedure.
THE RISK
Sedation obstructs the airway, in every patient.
Patients who breathe fine asleep at home still obstruct under propofol.
For the patients now filling ASC schedules - sleep apnea, obesity, heart disease - the margin is thinner still.
50%
Of anesthesia malpractice claims are related to complications from sedation.
3.3x
higher odds that a sleep-apnea patient needs an airway rescue under ambulatory sedation.
72%
Share of cardiac arrests during endoscopy sedation that began as airway problems.
It's estimated that between $9B and $13B is added to U.S. healthcare spending each year by procedural sedation adverse events — modeled from existing literature on healthcare economics.
WHAT PREVENTS IT
Two things work:
Seeing the breathing, and supporting it with pressure.
41%
Fewer severe oxygen drops when capnography is added to sedation monitoring.
66%
lower odds of cardiovascular complications when sleep apnea patients are on CPAP
25% → 8%
Hypoxia during endoscopy in obese patients when CPAP is applied.
Today these come as separate patient interfaces that pair with a monitor and a machine. But the machine is missing from the procedure room and ill-suited to travel with the patient...
We put both in one system, powered by the oxygen outlet.
THE MACHINE-FREE NON-INVASIVE PLATFORM
One system. See it, support it, open it.
O2rizon
A modular oxygen mask with Circumferential Oxygen Delivery and built‑in EtCO₂ breath monitoring that's
engineered to support the airway without removal of the scope, when oxygen levels drop.
™
™
SlideKick OPA
An adjustable airway fitting delivered through a bite block, with optional oxygen delivery and EtCO₂ breath monitoring layered on top.
™
Ye Circut
Machine-free CPAP from the medical gas cylinder or wall supply, in any location. From the moment of extubation, through patient transport, perioperative support, or procedural sedation.
Market Opportunity
The global anesthesia and respiratory device market was valued at $50.3B in 2023 and is projected to reach $97.1B by 2033 — and the shift toward procedures done outside the traditional operating room is accelerating that growth right where O2rizon™ lives.
$97.1B
Projected global anesthesia & respiratory device market by 2033, up from $50.3B in 2023
21%
Compound annual growth rate of procedures done in ASCs
>50%
Of all anesthesia cases expected to happen outside the operating room within the next decade
North America already leads the category, capturing 30.2% of global revenue
— and it's where Scopemed is launching first, with initial adoption targeted at settings most exposed to sedation‑related airway risk.
-
Tertiary care centers
-
GI Ambulatory Surgery Centers
-
Plastics surgery
Europe follows as the second phase.
WHO'S BEHIND IT
Built by clinicians, engineers, and operators.
Clinical Resources:
-
Saunders R, Davis JA, Kranke P, Weissbrod R, Whitaker DK, Lightdale JR. Clinical and economic burden of procedural sedation-related adverse events and their outcomes: analysis from five countries. Ther Clin Risk Manag. 2018;14:393-401. doi:10.2147/TCRM.S154720.
-
Walls JD, Weiss MS. Safety in non-operating room anesthesia (NORA). APSF Newsletter. 2019;34(1). Published June 1, 2019. Accessed September 2026. https://www.apsf.org/article/safety-in-non-operating-room-anesthesia-nora/
-
Saunders R, Struys MMRF, Pollock RF, Mestek M, Lightdale JR. Patient safety during procedural sedation using capnography monitoring: a systematic review and meta-analysis. BMJ Open. 2017;7(6):e013402. doi:10.1136/bmjopen-2016-013402.
† Internal engineering estimate for the combined SlideKick OPA + O2rizon™ rescue pathway — the oral airway paired with the mask's positive-pressure rescue breathing — based on bench testing; not yet substantiated by clinical outcomes data. Neither SlideKick OPA nor O2rizon™ has been cleared or approved by the FDA or any other regulatory body.